Matches in Wikidata for { <http://www.wikidata.org/entity/Q83582219> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q83582219 description "artículu científicu espublizáu en marzu de 2011" @default.
- Q83582219 description "im März 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83582219 description "scientific article published on 15 March 2011" @default.
- Q83582219 description "wetenschappelijk artikel" @default.
- Q83582219 description "наукова стаття, опублікована в березні 2011" @default.
- Q83582219 name "Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration" @default.
- Q83582219 name "Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration" @default.
- Q83582219 type Item @default.
- Q83582219 label "Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration" @default.
- Q83582219 label "Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration" @default.
- Q83582219 prefLabel "Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration" @default.
- Q83582219 prefLabel "Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration" @default.
- Q83582219 P1433 Q83582219-6A0020DE-6041-4B65-9126-D35FD55B8D2F @default.
- Q83582219 P1476 Q83582219-EBE1153D-FAE7-4501-98E4-E505B6ED15C0 @default.
- Q83582219 P2093 Q83582219-756798D0-B6EB-4769-9962-DF3C4B452321 @default.
- Q83582219 P2093 Q83582219-8B30A75D-3746-4EFB-826A-E24C2D70F844 @default.
- Q83582219 P2093 Q83582219-9EF91ADE-9431-48FD-8199-D22B9CAC6991 @default.
- Q83582219 P2093 Q83582219-A2223584-FCBB-43C6-9ABF-AEEBB40D186C @default.
- Q83582219 P2093 Q83582219-A4ED9422-B0D7-4093-BB93-B52DB34B4E31 @default.
- Q83582219 P2093 Q83582219-AB703CAF-7DD1-46C2-9FEE-E859622CA18D @default.
- Q83582219 P2093 Q83582219-E6FEA240-1C9A-4AA0-A021-9EC80292CDF8 @default.
- Q83582219 P2093 Q83582219-F6E9530D-3D7B-4CBF-8908-995E5AFB2E54 @default.
- Q83582219 P304 Q83582219-CFEB1E0A-6E1C-4D6C-B360-7C48D4799BA8 @default.
- Q83582219 P31 Q83582219-2B68FB25-51B0-4C51-988A-841E18587DBA @default.
- Q83582219 P356 Q83582219-DDBF56B2-D694-4E14-A13B-E08F70E01EFE @default.
- Q83582219 P433 Q83582219-246B4EAF-370B-411E-8A00-01DA4E35EAD0 @default.
- Q83582219 P478 Q83582219-69398F78-F393-4D35-B104-CC1F93DCB966 @default.
- Q83582219 P577 Q83582219-27D8CCA8-0780-43FF-98A8-BCFF38C67B38 @default.
- Q83582219 P698 Q83582219-352B7E20-8949-4873-B88B-7A849ED9A759 @default.
- Q83582219 P921 Q83582219-3F307DEF-9F95-4F15-BA96-8522CB58703D @default.
- Q83582219 P921 Q83582219-75A415EB-E34E-47AA-8B91-0890AF38E2D8 @default.
- Q83582219 P921 Q83582219-AF11960A-71E1-4AB6-B014-13379D4246D1 @default.
- Q83582219 P356 J.IJPHARM.2011.02.064 @default.
- Q83582219 P698 21392565 @default.
- Q83582219 P1433 Q6051539 @default.
- Q83582219 P1476 "Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration" @default.
- Q83582219 P2093 "Bi-Yun Huang" @default.
- Q83582219 P2093 "Cheng-Feng Luo" @default.
- Q83582219 P2093 "Liu Zhu" @default.
- Q83582219 P2093 "Min-Sheng Chen" @default.
- Q83582219 P2093 "Mu Yuan" @default.
- Q83582219 P2093 "Shi-Ming Liu" @default.
- Q83582219 P2093 "Wen Xiong" @default.
- Q83582219 P2093 "Xia-Wen Liu" @default.
- Q83582219 P304 "138-144" @default.
- Q83582219 P31 Q13442814 @default.
- Q83582219 P356 "10.1016/J.IJPHARM.2011.02.064" @default.
- Q83582219 P433 "1-2" @default.
- Q83582219 P478 "410" @default.
- Q83582219 P577 "2011-03-15T00:00:00Z" @default.
- Q83582219 P698 "21392565" @default.
- Q83582219 P921 Q323936 @default.
- Q83582219 P921 Q461809 @default.
- Q83582219 P921 Q61231 @default.